9.90p-0.10 (-1.00%)01 Mar 2024, 15:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Rua Life Sciences PLC Fundamentals

Company NameRua Life Sciences PLCLast Updated2024-03-01
IndustryMedical DevicesSectorHealthcare
Shares in Issue62.060 mMarket Cap£6.14 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.09EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0936Debt Equity Ratio0.0854
Asset Equity Ratio1.2732Cash Equity Ratio0.1320
Quick Ratio1.6673Current Ratio2.67
Price To Book Value1.6453ROCE0

Rua Life Sciences PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Rua Life Sciences PLC Company Financials

Assets202320222021
Tangible Assets£2.74 m£2.60 m£1.95 m
Intangible Assets£771,000.00£822,000.00£875,000.00
Investments000
Total Fixed Assets£3.51 m£3.42 m£2.83 m
Stocks£81,000.00£124,000.00£85,000.00
Debtors£588,000.00£915,000.00£862,000.00
Cash & Equivalents£1.48 m£2.96 m£6.29 m
Other Assets000
Total Assets£5.66 m£7.63 m£10.15 m
Liabilities202320222021
Creditors within 1 year£414,000.00£511,000.00£1.10 m
Creditors after 1 year£566,000.00£531,000.00£550,000.00
Other Liabilities000
Total Liabilities£980,000.00£1.04 m£1.65 m
Net assets£4.68 m£6.58 m£8.51 m
Equity202320222021
Called up share capital£1.11 m£1.11 m£12.95 m
Share Premium£23.57 m£23.57 m£11.73 m
Profit / Loss-£2.32 m-£2.36 m-£1.59 m
Other Equity£4.68 m£6.58 m£8.51 m
Preference & Minorities000
Total Capital Employed£4.68 m£6.58 m£8.51 m
Ratios202320222021
Debt Ratio£0.07£0.04£0.04
Debt-to-Equity£0.08£0.04£0.04
Assets / Equity1.27321.27321.2732
Cash / Equity0.13200.13200.1320
EPS-£0.09-£0.09-£0.08
Cash Flow202320222021
Cash from operating activities-£1.15 m-£2.35 m-£1.41 m
Cashflow before financing-£1.01 m-£2.42 m£5.27 m
Increase in Cash-£1.49 m-£3.33 m£4.32 m
Income202320222021
Turnover£2.18 m£1.63 m£1.53 m
Cost of sales£388,000.00£267,000.00£276,000.00
Gross Profit£1.79 m£1.36 m£1.25 m
Operating Profit-£2.31 m-£2.35 m-£1.55 m
Pre-Tax profit-£2.32 m-£2.36 m-£1.59 m

Rua Life Sciences PLC Company Background

SectorHealthcare
ActivitiesRUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives its major revenue from the USA and has a presence in Europe and the Rest of the world.
Latest Interim Date18 Dec 2023
Latest Fiscal Year End Date26 Jul 2023

Rua Life Sciences PLC Directors

AppointedNamePosition
2020-12-11Mr. James Gordon Wright Non-Executive Director
2013-12-03Mr. Francis Patrick Maguire Executive Director,Chief Executive
2012-12-31Mr. Jonathan Peter PitherNon-Executive Director
2023-12-18Mr. Ian Leslie ArdillNon-Executive Director
2016-10-31Mr. Edward Eddie McDaid Executive Director,Chief Executive Officer
2023-12-18Mr. William Donald Brown Executive Director,Chairman
2011-10-21Dr. Stuart Bernard Rollason Non-Executive Director
2015-06-01Mr. Roy Walter Mitchell Non-Executive Director,Finance Director
2023-12-18Mr. John McKenna Executive Director,Director of Clinical Marketing
2023-07-28Mr. John Louis Ely Non-Executive Director
2023-07-28Mr. Geoffrey Alan Berg Non-Executive Director
2021-08-10Mr. David Muir Richmond Executive Director,Chief Executive Officer
2023-07-28Dr. Caroline StrettonExecutive Director,Managing Director
2023-12-18Mr. Lachlan Arthur SmithExecutive Director,Chief Financial Officer
2023-07-28Dr. Iain Crawford AnthonyExecutive Director,Director of Clinical and Regulatory Affairs

Rua Life Sciences PLC Contact Details

Company NameRUA Life Sciences PLC
Addressc/o Kergan Stewart LLP, 163 Bath Street, Glasgow, G2 4SQ
Telephone
Websitehttps://www.rualifesciences.com

Rua Life Sciences PLC Advisors

RegistrarEquiniti Limited
StockbrokerFinnCap
Phone+44 2072200500
Fax+44 2076001659
AuditorGrant Thornton UK LLP
Phone(0116) 247 1234
Fax(0116) 247 1434
SolicitorDAC Beachcroft LLP
Phone+44 2072421011
Fax+44 2078316630
SolicitorBrodies LLP
Phone(0131) 228 3777
Fax(0131) 228 3878
BankBank of Scotland
Nominated AdviserFinnCap
Phone+44 2072200500
Fax+44 2076001659